DreamCIS INC.
Contract research organization providing clinical trial, post-marketing surveillance, and site management services to pharma and medtech clients.
As of 2026-10-10, DreamCIS INC. has 75 Korean MFDS device approvals, 7 Korean MFDS drug approvals, 3 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 2000 and listed on KOSDAQ in 2020, the company is a contract research organization (CRO). It provides clinical trials (Phase 1-3), post-marketing surveillance (PMS), non-interventional studies (NIS), regulatory consulting, and site management organization (SMO) services to pharmaceutical companies, medical device developers, and research institutions. In 2015 a Chinese CRO acquired an equity stake in the company, after which it pursued business expansion through investment.
Products & technology
- Clinical trial CRO servicesOutsourced clinical trial management for pharma, medtech, and research clients (Phase 1-3)
- Post-marketing surveillance (PMS/rPMS) servicesPost-marketing surveillance services for pharmaceuticals
- Non-interventional study (NIS) supportSupport for observational and non-interventional studies
- Regulatory affairs consultingRegulatory, reimbursement, and clinical support across Korea, US, Europe, Japan, China
- Site Management Organization (SMO) servicesAdministrative and operational support for clinical trial sites (subject recruitment, document/data management, IRB support)
Regulatory approvals
data.go.kr7 Korean MFDS drug approvals · 2001–2023 / 75 Korean MFDS device approvals · 1999–2026
- MFDSSubsidiary: (주)메디팁Gastroscope, video2026-01-13Product approval · Class 2수인 26-4045 호
- MFDSSubsidiary: (주)메디팁Colonoscope, video2025-12-23Product approval · Class 2수인 25-4746 호
- MFDSSubsidiary: (주)메디팁cavity varnish2025-12-18Product approval · Class 2수인 25-4733 호
- MFDSSubsidiary: (주)메디팁sealant, pit and fissure, glass-ionomer2025-12-18Product approval · Class 2수인 25-4732 호
- MFDSSubsidiary: (주)메디팁resin, filling, composit2025-12-16Product approval · Class 2수인 25-4722 호
- MFDSSubsidiary: (주)메디팁cavity liner2025-12-16Product approval · Class 2수인 25-4721 호
- MFDSSubsidiary: (주)메디팁Light source, endoscope2025-10-14Product approval · Class 2수인 25-4588 호
- MFDSSubsidiary: (주)메디팁Gastroscope, video2025-09-08Product approval · Class 2수인 25-4522 호
- MFDSSubsidiary: (주)메디팁Duodenoscope, video2025-08-18Product approval · Class 2수인 25-4465 호
- MFDSSubsidiary: (주)메디팁Colonoscope, video2025-08-11Product approval · Class 2수인 25-4451 호
- MFDSSubsidiary: (주)메디팁Gastroscope, video2024-11-07Product approval · Class 2수인 24-582 호
- MFDSSubsidiary: (주)메디팁Colonoscope, video2024-09-10Product approval · Class 2수인 24-449 호
Show 68 more
- MFDSSubsidiary: (주)메디팁Light source, endoscope2024-07-24Product approval · Class 2수인 24-366 호
- MFDSSubsidiary: (주)메디팁Duodenoscope, video2024-07-16Product approval · Class 2수인 24-352 호
- MFDSSubsidiary: (주)메디팁Dressing, absorbable, wound, biological origin2024-07-09Product approval · Class 4제허 24-465 호
- MFDSSubsidiary: (주)메디팁Gastric appetite-suppressing balloonRevoked2024-04-09Product approval · Class 2수허 24-83 호
- MFDSSubsidiary: (주)메디팁System, medical image processing deviceRevoked2024-02-20Product approval · Class 1수신 24-289 호
- MFDSSubsidiary: (주)메디팁Film processor for medical use, laserRevoked2024-02-19Product approval · Class 1수신 24-287 호
- MFDSSubsidiary: (주)메디팁Imager for medical useRevoked2024-02-14Product approval · Class 1수신 24-243 호
- MFDSSubsidiary: (주)메디팁Light source, endoscope2024-01-23Product approval · Class 2수인 24-40 호
- MFDSSubsidiary: (주)메디팁System, medical image processing device2024-01-09Product approval · Class 1수신 24-30 호
- MFDSSubsidiary: (주)메디팁Dressing, secondardy treatment, high-absorbent, foam/ sheet/ liquid/powder2024-01-03Product approval · Class 3제허 24-9 호
- MFDSSubsidiary: (주)메디팁Light source, endoscope2023-12-29Product approval · Class 2수인 23-4947 호
- MFDSSubsidiary: (주)메디팁Light source, endoscope2023-12-22Product approval · Class 2수인 23-4929 호
- MFDS drugSubsidiary: (주)메디팁Tavneos(Avacopan) 10mg hard capsuleRevoked2023-09-21Drug · Prescription · Approval202302792
- MFDSSubsidiary: (주)메디팁Dressing, secondardy treatment, high-absorbent, foam/ sheet/ liquid/powder2023-04-26Product approval · Class 3제허 23-543 호
- MFDSSubsidiary: (주)메디팁Dressing, secondardy treatment, high-absorbent, foam/ sheet/ liquid/powder2022-08-24Product approval · Class 3제허 22-574 호
- MFDSSubsidiary: (주)메디팁Radiation shield, spectacles2022-08-09Product approval · Class 1수신 22-1382 호
- MFDS drugSubsidiary: (주)메디팁Afluria quad PFS.Revoked2020-03-16Drug · Prescription · Approval202001826
- MFDSSubsidiary: (주)메디팁Colonoscope, video2019-10-24Product approval · Class 2수인 19-4720 호
- MFDSSubsidiary: (주)메디팁Gastroscope, video2019-10-23Product approval · Class 2수인 19-4716 호
- MFDSSubsidiary: (주)메디팁Light source, endoscope2019-10-14Product approval · Class 2수인 19-4682 호
- MFDSSubsidiary: (주)메디팁impression, pre-treatment material, gingival retraction cord2019-06-03Product approval · Class 2수인 19-4346 호
- MFDSSubsidiary: (주)메디팁impression, pre-treatment material, gingival retraction cord2019-06-03Product approval · Class 2수인 19-4345 호
- MFDSSubsidiary: (주)메디팁impression, pre-treatment material, gingival retraction cord2019-06-03Product approval · Class 2수인 19-4348 호
- MFDSSubsidiary: (주)메디팁System, medical image processing device2019-05-29Product approval · Class 1수신 19-1288 호
- MFDSSubsidiary: (주)메디팁Dressing, secondardy treatment, high-absorbent, foam/ sheet/ liquid/powder2018-11-26Product approval · Class 3제허 18-754 호
- MFDSSubsidiary: (주)메디팁Soft contact lens, daily-wear2018-03-08Product approval · Class 2수허 18-86 호
- MFDSSubsidiary: (주)메디팁Protein analyzer, electronic, plasmonicRevoked2017-02-24Product approval · Class 1수신 17-607 호
- MFDSSubsidiary: (주)메디팁impression, pre-treatment material, gingival retraction cord2016-09-23Product approval · Class 2수인 16-4521 호
- MFDSSubsidiary: (주)메디팁Gel for medical use, non-sterilizedRevoked2016-07-06Product approval · Class 1수신 16-1763 호
- MFDSSubsidiary: (주)메디팁Endotherapy forceps, reusableRevoked2016-05-31Product approval · Class 1수신 16-1427 호
- MFDSSubsidiary: (주)메디팁Soft contact lens, daily-wear2015-11-05Product approval · Class 2수허 15-1645 호
- MFDSSubsidiary: (주)메디팁adhesive, dentine, resin2015-05-27Product approval · Class 2수인 15-1022 호
- MFDSSubsidiary: (주)메디팁의료영상전송장치소프트웨어Revoked2015-03-24Product approval · Class 2수허 15-670 호
- MFDSSubsidiary: (주)메디팁휴대형의료영상전송장치소프트웨어Revoked2015-03-05Product approval · Class 2수인 15-547 호
- MFDSSubsidiary: (주)메디팁implant, endosseous, drill/handpiece2014-10-21Product approval · Class 1서울 수신 14-2622 호
- MFDSSubsidiary: (주)메디팁implant, endosseous, drill/handpiece2014-05-15Product approval · Class 1서울 수신 14-1467 호
- MFDSSubsidiary: (주)메디팁implant, endosseous, drill/handpiece2014-05-15Product approval · Class 1서울 수신 14-1463 호
- MFDSSubsidiary: (주)메디팁Soft contact lens, daily-wear2014-05-09Product approval · Class 2수허 14-1872 호
- MFDSSubsidiary: (주)메디팁implant, endosseous, hand instrument2014-04-03Product approval · Class 1서울 수신 14-1134 호
- MFDSSubsidiary: (주)메디팁Graft/prosthesis, biomaterial2013-05-08Product approval · Class 4수허 13-815 호
- MFDSSubsidiary: (주)메디팁implant, endosseous, drill/handpiece2013-04-03Product approval · Class 1서울 수신 13-660 호
- MFDSSubsidiary: (주)메디팁material, denture, other adhesiveRevoked2012-08-03Product approval · Class 3수허 12-1169 호
- MFDSSubsidiary: (주)메디팁Protein analyzer, electronic, plasmonicRevoked2012-07-20Product approval · Class 1서울 수신 12-1517 호
- MFDSSubsidiary: (주)메디팁implant, endosseous, superstructure2012-07-05Product approval · Class 2수인 12-1025 호
- MFDSSubsidiary: (주)메디팁implant, endosseous, systemRevoked2011-12-20Product approval · Class 3수허 11-1487 호
- MFDSSubsidiary: (주)메디팁implant, endosseous, hand instrument2011-12-20Product approval · Class 1서울 수신 11-2261 호
- MFDSSubsidiary: (주)메디팁implant, endosseous, drill/handpiece2011-12-19Product approval · Class 1서울 수신 11-2251 호
- MFDSSubsidiary: (주)메디팁implant, endosseous, screw driver2011-12-19Product approval · Class 1서울 수신 11-2252 호
- MFDSSubsidiary: (주)메디팁치과용임플란트기공재료Revoked2011-12-19Product approval · Class 1서울 수신 11-2258 호
- MFDSSubsidiary: (주)메디팁implant, endosseous, superstructure2011-12-15Product approval · Class 2수허 11-1466 호
- MFDSSubsidiary: (주)메디팁implant, endosseous, superstructure2011-12-15Product approval · Class 2수허 11-1464 호
- MFDSSubsidiary: (주)메디팁implant, endosseous, fixtureRevoked2011-12-15Product approval · Class 3수허 11-1465 호
- MFDSSubsidiary: (주)메디팁implant, endosseous, superstructure2011-12-12Product approval · Class 2수허 11-1445 호
- MFDSSubsidiary: (주)메디팁Soft contact lens, daily-wearRevoked2009-06-16Product approval · Class 2수허 09-564 호
- MFDSSubsidiary: (주)메디팁Soft contact lens, daily-wearRevoked2009-06-16Product approval · Class 2수허 09-563 호
- MFDSSubsidiary: (주)메디팁material, dentine, desensitizer2007-11-23Product approval · Class 2수인 07-1012 호
- MFDS drugSubsidiary: (주)메디팁Healon Injection2007-08-09Drug · Prescription · Notification200709352
- MFDSSubsidiary: (주)메디팁root canal filler, endodontic, others2006-11-14Product approval · Class 2수인 06-1170 호
- MFDS drugSubsidiary: (주)메디팁Ucerax Syrup2006-05-25Drug · Prescription · Approval200605269
- MFDS drugSubsidiary: (주)메디팁Healon 5 InjectionRevoked2006-03-23Drug · Prescription · Notification200603998
- MFDSSubsidiary: (주)메디팁material, dentine, desensitizer2005-11-08Product approval · Class 2수인 05-1052 호
- MFDSSubsidiary: (주)메디팁sealant, pit and fissure, glass-ionomerRevoked2005-02-23Product approval · Class 2수인 05-164 호
- MFDSSubsidiary: (주)메디팁resin, filling, compositRevoked2005-01-03Product approval · Class 2수인 05-2 호
- MFDSSubsidiary: (주)메디팁cavity linerRevoked2005-01-03Product approval · Class 2수인 05-4 호
- MFDSSubsidiary: (주)메디팁cavity varnishRevoked2005-01-03Product approval · Class 2수인 05-5 호
- MFDSSubsidiary: (주)메디팁sealant, pit and fissure, resin2004-11-04Product approval · Class 2수인 04-1444 호
- MFDS drugSubsidiary: (주)메디팁Pantogar Cap.2002-12-24Drug · OTC · Notification200210304
- MFDSSubsidiary: (주)메디팁Spinal internal fixation system, intervertebral bodyRevoked2001-10-29Product approval · Class 3수허 01-1274 호
Showing the 80 most recent of 82 records.
Clinical trials
data.go.kr15 MFDS clinical trial authorisations · 2017–2026 (Phase 3 4 · Phase 2 4 · Phase 1 2 · Phase 1/2 2 · Phase 2a 1)
- Phase 1NS-3422026-08-21
3 trial sites
- Phase 3BGM0504주사제2.5밀리그램,5밀리그램,10밀리그램,15밀리그램2026-07-29
1 trial site
- Phase 2aDB-1303주2024-08-29
6 trial sites
- Phase 3Teclistamab (JNJ-64007957)2022-10-07
6 trial sites
- Phase 2LAE0012022-03-17
5 trial sites
- Phase 1bSIR1-3652022-01-05
14 trial sites
- Phase 3AN20252021-04-01
9 trial sites
- Phase 3Rimegepant (BHV-3000)2020-06-29
26 trial sites
- Phase 1/2AZD42052019-05-13
2 trial sites
- Phase 1MT-5199 캡슐2019-04-05
1 trial site
- Phase 2/3AZD37592018-08-03
9 trial sites
- Phase 2ATG-0082018-06-22
4 trial sites
Show 3 more
- Phase 2AZD37592018-04-26
- Phase 2TJ 3012017-07-05
4 trial sites
- Phase 1/2PLX33972017-02-06
3 trial sites
Key disclosures
KRX KIND via OpenDARTPublications
PubMed · affiliation-matched- Potential Bias in Self-Controlled Case Series Design: Impact of Incident Versus Prevalent Scenarios of Exposure and Outcome.
Pharmacoepidemiology and drug safety · 2025-10 · Jung K, Byun SJ, Lim G 외 4
- In reply.
Menopause (New York, N.Y.) · 2021-05 · Lee JH, Cho S, Kim YC 외 1
- Effect of sex hormones on coronavirus disease 2019: an analysis of 5,061 laboratory-confirmed cases in South Korea.
Menopause (New York, N.Y.) · 2020-12 · Lee JH, Kim YC, Cho SH 외 6
Patents
KIPRIS · applicant-matched- Subsidiary: (주)메디팁WOUND DRESSING COMPOSITION WITH EXCELLENT HEMOSTATIC AND ANTI-ADHESION EFFECTS AND USE THEREOF
PCT · Published · 2024-06 · Application PCT/KR2024/007775
- Subsidiary: (주)메디팁지혈 및 유착방지 효과가 우수한 창상피복재 조성물 및 이의 용도
Registered · 2023-12 · Application 1020230189567
CN · Published · 2020-11 · Application 202080080438.9
- Subsidiary: (주)메디팁WOUND DRESSING MATERIAL FOR HEMOSTASIS AND WOUND TREATMENT, AND METHOD FOR PREPARING SAME
PCT · Published · 2020-11 · Application PCT/KR2020/016458
- Subsidiary: (주)메디팁지혈 및 상처치유용 창상피복재 및 이의 제조 방법
Registered · 2019-11 · Application 1020190151554
- Subsidiary: (주)메디팁Method for manufacturing wound covering material using biopolymer and wound covering material using biopolymer manufactured by the same
CN · Published · 2016-01 · Application 201680000369.X
- Subsidiary: (주)메디팁Method for preparing wound dressing material using biopolymer and wound dressing material using biopolymer prepared thereby
US · Registered · 2016-01 · Application 15033187
- Subsidiary: (주)메디팁METHOD FOR PREPARING WOUND COVERING MATERIAL USING BIOPOLYMER AND WOUND COVERING MATERIAL USING BIOPOLYMER, PREPARED BY SAME METHOD
PCT · Published · 2016-01 · Application PCT/KR2016/000693
- Subsidiary: (주)메디팁바이오폴리머를 이용한 창상 피복재의 제조방법 및 이를 이용하여 제조된 바이오폴리머를 이용한 창상 피복재
Registered · 2016-01 · Application 1020160006839
- Subsidiary: (주)메디팁자가 미세 유화형 약물 전달 시스템을 이용하는 루테인의 경구 투여용 약제 조성물
Registered · 2010-07 · Application 1020100067772
AI reads
MAA server logs · IP-verifiedPulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.
Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.
Collected as raw material for future answers.
Queries from users who connected this index to their own AI.
- OpenAIOAI-SearchBot104
- GoogleGoogleOther19
- PerplexityPerplexityBot3
- AnthropicClaudeBot2
- MicrosoftBingbot1
Measured since Aug 27, 2026 · 5 AI engines · last read Oct 9, 2026
User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.
Connect this company index directly to your AI
Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for DreamCIS INC. and every listed Korean medical, bio and AI company.
How to connect (MCP)Companies approved for the same productsHealthcare Infrastructure
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
Founded in 1964 and KOSPI-listed in 1991, Shinhung manufactures and distributes dental equipment and materials.
MITECH CO.,LTD., founded in 1991 and listed on KOSDAQ in 2018, makes non-vascular stents and distributes Fujifilm endoscopy equipment.
DIO Corporation, established in 1988 and listed on KOSDAQ in 2000, manufactures and sells dental implants.
Founded in 1926 and listed on the KOSPI in 1962, Yuhan Corporation is a comprehensive pharmaceutical company known for its innovative drug Leclaza.
Founded in 2016 and listed on KOSDAQ in 2017, DENTIS manufactures dental implants, medical LED lighting, and dental 3D printers.
KOSDAQ-listed medical device company producing ESD/EMR endoscopic devices such as ClearCut Knife and Clear-Jet Injector.
KOSDAQ-listed minimally invasive surgical device company developing the ArtiSential multi-jointed laparoscopic instrument and ArtiSeal vessel sealer.
Founded in 1997 and KOSDAQ-listed in 2015, CG MedTech makes orthopedic medical devices and also operates an electric energy business.
KOSDAQ-listed medical device company manufacturing synthetic bioresorbable suture yarn and dental root canal filling materials.
Alpha AI, founded in 1995 and KOSDAQ-listed in 2000, manufactures biocompatible metal implants and surgical instruments.
Dong-A ST, spun off from Dong-A Socio Holdings in 2013 and KOSPI-listed, makes prescription drugs like Growtropin, Stillen, and Bacchus.
KOSDAQ-listed comprehensive healthcare and pharmaceutical company behind the gum treatment Insadol and the wound-care ointment Madecassol.
Sources and updates
Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- Approvals & clinical trials
- Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
- Key disclosures
- KRX KIND via OpenDART exchange filings — updated daily
- Global clinical trials
- ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
- Financials
- DART corporate disclosure filings — annual
- Publications
- PubMed (US National Library of Medicine) — affiliation-matched, updated daily
- Patents
- KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
- AI reads
- Our server logs, IP-verified every 6 hours
- AI visibility
- Measured 2026-10-01
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition